First Diagnosis of Immunoglobulin A Nephropathy Following SARS-CoV-2 mRNA Vaccination in Japan
暂无分享,去创建一个
Yusuke Suzuki | Hitoshi Suzuki | N. Tsuboi | K. Haruhara | T. Yokoo | S. Tomita | K. Joh | Hiroyuki Ueda | A. Shimizu | S. Yokote | M. Okabe | Harumi Saeki | R. Aoki | T. Sasaki | H. Ueda
[1] V. D’Agati,et al. Histologic correlates of gross hematuria following Moderna COVID-19 vaccine in patients with IgA nephropathy , 2021, Kidney International.
[2] N. Bouvier,et al. Gross hematuria following SARS-CoV-2 vaccination in patients with IgA nephropathy , 2021, Kidney International.
[3] John Wang,et al. A case of gross hematuria and IgA nephropathy flare-up following SARS-CoV-2 vaccination , 2021, Kidney International.
[4] B. Rovin,et al. Gross Hematuria Following Vaccination for SARS-CoV2 in Two Patients with IgA Nephropathy , 2021, Kidney International.
[5] A. Shimizu,et al. A cross-sectional study in patients with IgA nephropathy of correlations between clinical data and pathological findings at the time of renal biopsy: a Japanese prospective cohort study , 2021, Clinical and Experimental Nephrology.
[6] J. Mascola,et al. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine , 2020, The New England journal of medicine.
[7] P. Dormitzer,et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine , 2020, The New England journal of medicine.
[8] V. D’Agati,et al. Evidence from the Oxford Classification cohort supports the clinical value of subclassification of focal segmental glomerulosclerosis in IgA nephropathy. , 2017, Kidney international.
[9] J. Scholey,et al. Remission of proteinuria improves prognosis in IgA nephropathy. , 2007, Journal of the American Society of Nephrology : JASN.